Literature DB >> 372234

The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum.

R J Ulevitch, A R Johnston.   

Abstract

Normal rabbit serum reduces the buoyant density of lipopolysaccharide (LPS) from Escherichia coli 0111:B4 (d = 1.44 g/cm3) and Salmonella minnesota R595 (d = 1.38 g/cm3) to a value less than g/cm3. This density shift is associated with the inhibition of a number of endotoxic activities of the LPS; namely, the pyrogenic activity, the ability to produce an immediate neutropenia in rabbits, lethality in adrenalectomized mice, and anticomplementary activity. A qualitatively similar change in buoyant density was observed to occur after intravenous injection of the LPS into rabbits. Preliminary evidence suggests that the density shift does not occur as a result of the degradation of the glycolipid backbone of the LPS. These data suggest that the interactions of LPS with plasma (or serum) components leading to reduction in buoyant density may account for a major pathway of LPS detoxification.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 372234      PMCID: PMC371897          DOI: 10.1172/JCI109252

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  RESTORATION OF ENDOTOXIN ACTIVITY FOLLOWING ALTERATION BY PLASMA.

Authors:  J A RUDBACH; A G JOHNSON
Journal:  Nature       Date:  1964-05-23       Impact factor: 49.962

2.  Characteristics of endotoxin altering fractions derived from normal human serum.

Authors:  M YOSHIOKA; A G JOHNSON
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

3.  Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.

Authors:  M A CYNKIN; G ASHWELL
Journal:  Nature       Date:  1960-04-09       Impact factor: 49.962

4.  Reduction of febrile response to bacterial polysaccharide following incubation with serum.

Authors:  D P RALL; J R GASKINS; M G KELLY
Journal:  Am J Physiol       Date:  1957-03

5.  The preparation and characterization of a radioiodinated bacterial lipopolysaccharide.

Authors:  R J Ulevitch
Journal:  Immunochemistry       Date:  1978-03

6.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

7.  Isolation from human serum of an inactivator of bacterial lipopolysaccharide.

Authors:  K J Johnson; P A Ward; S Goralnick; M J Osborn
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

8.  Inactivation of endotoxin by a humoral component. II. Interaction of endotoxin with serum and plasma.

Authors:  R C SKARNES; F S ROSEN; M J SHEAR; M LANDY
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

9.  Inactivation of endotoxin by a humoral component. III. Role of divalent cation and a dialyzable component.

Authors:  F S ROSEN; R C SKARNES; M LANDY; M J SHEAR
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

10.  PATHOGENIC FACTORS IN VASULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS.

Authors:  W T KNIKER; C G COCHRANE
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  54 in total

1.  Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Jari Metso; Andreas Kateifides; Taru Meri; T Sakari Jokiranta; Artur Muszyński; Joanna Radziejewska-Lebrecht; Vassilis Zannis; Mikael Skurnik; Matti Jauhiainen
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

2.  Use of two-dimensional gas chromatography with electron-capture detection for the measurement of lipopolysaccharides in peritoneal fluid and plasma from rats with induced peritonitis.

Authors:  A Sonesson; L Larsson; R Andersson; N Adner; K G Tranberg
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form.

Authors:  M Navab; G P Hough; B J Van Lenten; J A Berliner; A M Fogelman
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

Review 4.  Roles of interferon produced in physiological conditions. A speculative review.

Authors:  V Bocci
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

5.  Release of endotoxic lipopolysaccharide by sensitive strains of Escherichia coli submitted to the bactericidal action of human serum.

Authors:  J Demonty; J De Graeve
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

6.  Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.

Authors:  L Masucci-Magoulas; P Moulin; X C Jiang; H Richardson; A Walsh; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Uptake and subcellular localization of bacterial lipopolysaccharide in the adrenal gland.

Authors:  J C Mathison; R J Ulevitch
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

8.  Turbidimetric method for quantifying serum inhibition of Limulus amoebocyte lysate.

Authors:  T J Novitsky; P F Roslansky; G R Siber; H S Warren
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 9.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

Review 10.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.